Researchers discover how to predict the efficacy of one of the most widely used drugs against breast cancer

Cloud computing banner background for smart city

Precision oncology aims at pointing out which drug is likely to work in every specific cancer patient. At the moment these targeted therapies are only available for 5% of cancers. The study carried out by CNIO researchers Miguel A. Quintela-Fandino and Silvana Mouron, together with oncology units from several Spanish hospitals, has discovered a way to identify whether one of the most commonly used drugs in conventional chemotherapy for various types of cancer, paclitaxel, will be effective in each patient.

Elon Musk is turning your Tesla into a Steam gaming rig

Previous article

Patients with treatment resistant depression at higher risk of death 

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations